Angiogenesis in the progression of cutaneous squamous cell carcinoma: An immunohistochemical study of endothelial markers

Clinics

Volumn 66, Issue 3, 2011, Pages 465-468

  Florence, Michelle Etienne Baptistella ^a   Massuda, Juliana Yumi ^a   Bröcker, Eva Bettina ^a   Metze, Konradin ^b   Cintra, Maria Letícia ^b   de Souza, Elemir Macedo ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Actinic; CD105 antigen; CD34 antigen; Human; Keratosis; Pathologic neovascularization; Skin neoplasms

Indexed keywords

CD34 ANTIGEN; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ACTINIC KERATOSIS; ARTICLE; CELL COUNT; HUMAN; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; SKIN; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; VASCULARIZATION;

ANTIGENS, CD; ANTIGENS, CD34; CARCINOMA, SQUAMOUS CELL; CELL COUNT; HUMANS; KERATOSIS, ACTINIC; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CELL SURFACE; SKIN; SKIN NEOPLASMS;

EID: 79957600238     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000300018     Document Type: Article

References (23)

1. Diepgen TL, Mahler V. The Epidemiology of Skin Cancer. Br J Dermatol. 2002;146(suppl 61):1-6, doi: 10.1046/j.1365-2133.146.s61.2.x.
2. Ackerman AB, Mones JM. Solar (actinic) Keratosis is Squamous Cell Carcinoma. Br J Dermatol. 2006:155;9-22, doi: 10.1111/j.1365-2133.2005. 07121.x.
3. Hanahan D, Weinberg A. The Hallmarks of Cancer. Cell 2000;100:57-70, doi: 10.1016/S0092-8674(00)81683-9.
4. Bergers G, Benjamin LE. Tumorigenesis and the Angiogenic Switch. Nat Rev Cancer. 2003;3:401-10, doi: 10.1038/nrc1093.
5. Hanahan D., Folkman J. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis. Cell. 1996;86:353-64, doi: 10. 1016/S0092-8674(00)80108-7.
6. Sharma S, Sharma MC, Sarkar C. Morphology of Angiogenesis in Human Cancer: A Conceptual Overview, Histoprognostic Perspective and Significance of Neoangiogenesis. Histopathology. 2005;46:481-9, doi: 10.1111/j.1365-2559.2005.02142.x.
7. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. Heterogeneity of Angiogenesis and Blood Vessel Maturation in Human Tumors: Implications for Antiangiogenic Tumor Therapies. Cancer Res. 2000;60:1388-93.
8. Fonsatti E, Altomonte M, Nicotra MR, Natali PG, Maio M. Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels. Oncogene 2003;22:6557-63, doi: 10.1038/sj.onc.1206813.
9. Fonsatti E, Del Vecchio L, Altomonte M, Sigalotti L, Nicotra MR, Coral S, et al. Endoglin: An Accessory Component of the TGF-b-Binding Receptor-Complex With Diagnostic, Prognostic, and Bioimmunotherapeutic Potential in Human Malignancies J Cell Physiol. 2001;188:1-7.
10. Minhajat R, Mori D, Yamasaki F, Sugita Y, Satoh T, Tokunaga O. Organspecific endoglin (CD105) expression in the angiogenesis of human cancers. Pathol Int. 2006;56:717-23, doi: 10.1111/j.1440-1827.2006.02037.x.
11. Fox SB and Harris AL. Histological Quantitation of Tumour Angiogenesis. APMIS. 2004;112:413-30, doi: 10.1111/j.1600-0463.2004. apm11207-0803.x.
12. Vermeulen PB, Gasparini G, Fox SB, Colpaert C, Marson LP, Gion M. Second International Consensus on the Methodology and Criteria of Evaluation of Angiogenesis Quantification in Solid Human Tumours. Eur J Cancer. 2002;38:1564-79.
13. Hansen S, Sorensen FB, Vach W, Grabau DA, Bak M, Rose C. Microvessel Density Compared with the Chalkley Count in a Prognostic Study of Angiogenesis in Breast Cancer Patients. Histopathology. 2004;44:428-36, doi: 10.1111/j.1365-2559.2004.01848.x.
14. Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol. 2000;42: S23-4, doi: 10.1067/mjd.2000.103339.
15. Lee AD, Jorizzo JL. Optimizing Management of Actinic Keratosis and Photodamaged Skin: Utilizing a Stepwise Approach. Cutis. 2009;84:169-75.
16. Fuchs A, Marmur E. The Kinetics of Skin Cancer: Progression of Actinic Keratosis to Squamous Cell Carcinoma. Dermatol Surg. 2007;33:1099-101, doi: 10.1111/j.1524-4725.2007.33224.x.
17. Hasan J, Byers R, Jayson GC. Intra-tumoural Microvessel Density in Human Solid Tumours. Br J Cancer. 2002;86:1566-77.
18. Bluff JE, Menakuru SR, Cross SS, Higham SE, Balasubramanian SP, Brown NJ, et al. Angiogenesis is Associated With the Onset of Hyperplasia in Human Ductal Breast Disease. Br J Cancer. 2009; 101:666-72.
19. Smith-McCune K, Zhu Y-H, Hanahan D, Arbeit J. Cross-species Comparison of Angiogenesis during the Premalignant Stages of Squamous Carcinogenesis in the Human Cervix and K14-HPV16 Transgenic Mice. Cancer Res. 1997;57:1294-300.
20. Coussens LM, Hanahan D, Arbeit JM. Genetic Predisposition and Parameters of Malignant Progression in K14-HPV 16 Transgenic Mice. Am J Pathol. 1996;149:1899-1917.
21. Strieth S, Hartschuh W, Pilz L, Fusenig NE. Angiogenic Switch Occurs Late in Squamous Cell Carcinomas of Human Skin. Br J Cancer. 2000;82:591-600.
22. Nijsten T, Colpaert CG, Vermeulen PB, Harris AL, Van Marck E, Lambert J. Cyclooxygenase-2 Expression and Angiogenesis in Squamous Cell Carcinoma of the Skin and its Precursors: A Paired Immunohistochemical Study of 35 Cases. Br J Dermatol. 2004;151:837-45, doi: 10.1111/j.1365-2133.2004.06214.x.
23. Hlatky L, Hahnfeldt P, Folkman J. Clinical Application of Antiangiogenic Therapy: Microvessel Density, What it Does and Doesn't Tell Us. J Natl Cancer Inst. 2002;94;883-93.